Aryl hydrocarbon receptor counteracts pharmacological efficacy of doxorubicin via enhanced AKR1C3 expression in triple negative breast cancer cells.
暂无分享,去创建一个
N. Hiruta | H. Bujo | K. Nemoto | Kensuke Terai | R. Kizu | Yuichiro Kanno | Youngjin Park | Nao Saito | Noriko Sanada | Naoya Yamashita